Upcoming Event: The 3rd DIA China Annual Meeting
3/11/2011
Dates: May 15 - 18, 2011
Venue: Crowne Plaza Sun Palace, Beijing, China
Contact: Mr. Fei Xie
Tel: +86 10 5923 1109
As a global neutral platform, DIA invites you to attend the 3rd DIA China Annual Meeting, which will explore the latest developments within the China pharmaceutical industry, explore ideas that will impact global health, and featuring open debate by senior professionals, top academics and high-level officials from pharma, R&D, and regulatory affairs.
As China unveils its 12th Five-Year Plan, the Chinese biopharmaceutical industry once again draws global attention as one of the investment heavyweights of the biopharmaceutical industry. Billions of special funds are pouring in.
Yet, new policies and industry reorganization have placed China's pharma industry at a critical stage; future elevation and sustainable development of the industry require revisiting quality and standards.
China's new medical reform has both rationalized the healthcare system and spiked enthusiasm to engage in new drug research. With quality throughout the whole manufacturing process, and world-class normative clinical research, the future of China’s drug innovation is golden.
KEY SESSIONS AND TOPICS
- Drug Standards and Quality;
- Clinical Research and Drug Safety;
- Regulations & Implementation;
- Data Management and Statistics;
- Medical and Scientific Affairs;
- Clinical Development and Capacity Building; and